Viability

Explaining the Crosswalk Between Singapore’s AI Verify Testing Framework and The U.S. NIST AI Risk Management Framework

Retrieved on: 
Wednesday, January 24, 2024

On October 13, 2023, Singapore’s Infocomm Media Development Authority (IMDA) and the U.S.’s National Institute of Standards and Technology (NIST) published a “Crosswalk” of IMDA’s AI Verify testing framework and NIST’s AI Risk Management Framework (AI RMF). Developed under the aegis of the Singapore–U.S. Partnership for Growth and Innovation, the Crosswalk is a mapping document [?]

Key Points: 


On October 13, 2023, Singapore’s Infocomm Media Development Authority (IMDA) and the U.S.’s National Institute of Standards and Technology (NIST) published a “Crosswalk” of IMDA’s AI Verify testing framework and NIST’s AI Risk Management Framework (AI RMF). Developed under the aegis of the Singapore–U.S. Partnership for Growth and Innovation, the Crosswalk is a mapping document [?]

GDHG Investors: Contact Robbins LLP for Information About the Golden Heaven Group Holdings Ltd. Class Action Lawsuit

Retrieved on: 
Wednesday, January 10, 2024

SAN DIEGO, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Golden Heaven Group Holdings Ltd. (NASDAQ: GDHG) securities between April 13, 2023 and November 13, 2023.

Key Points: 
  • SAN DIEGO, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Golden Heaven Group Holdings Ltd. (NASDAQ: GDHG) securities between April 13, 2023 and November 13, 2023.
  • Golden Heaven has stated that it “manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities.
  • For more information, submit a form , email Aaron Dumas, Jr., or give us a call at (800) 350-6003.
  • What Now: Similarly situated shareholders may be eligible to participate in the class action against Golden Heaven Holdings Ltd. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP.

GDHG Shareholders With Large Losses Should Contact Securities Law Firm Robbins LLP for Information About Their Rights and Remedies Against Golden Heaven Group Holdings Ltd.

Retrieved on: 
Tuesday, January 2, 2024

Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Golden Heaven Group Holdings Ltd. (NASDAQ: GDHG) securities between April 13, 2023 and November 13, 2023.

Key Points: 
  • Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Golden Heaven Group Holdings Ltd. (NASDAQ: GDHG) securities between April 13, 2023 and November 13, 2023.
  • Golden Heaven has stated that it “manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities.
  • For more information, submit a form , email Aaron Dumas, Jr., or give us a call at (800) 350-6003.
  • What Now: Similarly situated shareholders may be eligible to participate in the class action against Golden Heaven Holdings Ltd. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP.

GDHG Class Action Alert: Robbins LLP Reminds Shareholders of Lead Plaintiff Deadline in Golden Heaven Group Holdings Ltd. Class Action

Retrieved on: 
Thursday, December 28, 2023

SAN DIEGO, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Golden Heaven Group Holdings Ltd. (NASDAQ: GDHG) securities between April 13, 2023 and November 13, 2023.

Key Points: 
  • SAN DIEGO, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Golden Heaven Group Holdings Ltd. (NASDAQ: GDHG) securities between April 13, 2023 and November 13, 2023.
  • Golden Heaven has stated that it “manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities.
  • What Now: Similarly situated shareholders may be eligible to participate in the class action against Golden Heaven Holdings Ltd. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Golden Heaven Group Holdings Ltd. (GDHG)  

Retrieved on: 
Thursday, December 21, 2023

SAN DIEGO, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Golden Heaven Group Holdings Ltd. (NASDAQ: GDHG) securities between April 13, 2023 and November 13, 2023.

Key Points: 
  • SAN DIEGO, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Golden Heaven Group Holdings Ltd. (NASDAQ: GDHG) securities between April 13, 2023 and November 13, 2023.
  • Golden Heaven has stated that it “manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities.
  • What Now: Similarly situated shareholders may be eligible to participate in the class action against Golden Heaven Holdings Ltd. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

OTLK STOCK ALERT: Robbins LLP Reminds Investors of January 2, 2024, Lead Plaintiff Deadline in the Class Action Filed Against Outlook Therapeutics, Inc.

Retrieved on: 
Saturday, December 16, 2023

Outlook is a late clinical-stage biopharmaceutical company that focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications.

Key Points: 
  • Outlook is a late clinical-stage biopharmaceutical company that focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications.
  • For more information, submit a form , email Aaron Dumas, Jr., or give us a call at (800) 350-6003.
  • What Now: Similarly situated shareholders may be eligible to participate in the class action against Outlook Therapeutics, Inc. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Robbins LLP Reminds Brainstorm Cell Therapeutics Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Against BCLI

Retrieved on: 
Friday, December 15, 2023

SAN DIEGO, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action lawsuit on behalf of persons and entities that purchased or otherwise acquired Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) securities between August 15, 2022 and September 27, 2023.

Key Points: 
  • SAN DIEGO, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action lawsuit on behalf of persons and entities that purchased or otherwise acquired Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) securities between August 15, 2022 and September 27, 2023.
  • Brainstorm Cell is a biotechnology company that develops and commercializes autologous cellular therapies for the treatment of neurodegenerative diseases.
  • What Now: Similarly situated shareholders may be eligible to participate in the class action against Brainstorm Cell Therapeutics Inc. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

OTLK STOCK NEWS: Investors with Significant Losses in Outlook Therapeutics, Inc. Should Contact Robbins LLP for Information About the Outlook Therapeutics, Inc. Class Action

Retrieved on: 
Tuesday, November 21, 2023

Outlook is a late clinical-stage biopharmaceutical company that focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications.

Key Points: 
  • Outlook is a late clinical-stage biopharmaceutical company that focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications.
  • For more information, submit a form , email Aaron Dumas, Jr., or give us a call at (800) 350-6003.
  • On August 30, 2023, Outlook issued a press release announcing that the FDA had issued a complete response letter (“CRL”) to the ONS-5010 BLA.
  • What Now: Similarly situated shareholders may be eligible to participate in the class action against Outlook Therapeutics, Inc. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP.

Brainstorm Cell Therapeutics Inc. Class Action Reminder: Contact Robbins LLP for Information About the BCLI Class Action

Retrieved on: 
Tuesday, November 21, 2023

SAN DIEGO, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action lawsuit on behalf of persons and entities that purchased or otherwise acquired Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) securities between August 15, 2022 and September 27, 2023.

Key Points: 
  • SAN DIEGO, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action lawsuit on behalf of persons and entities that purchased or otherwise acquired Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) securities between August 15, 2022 and September 27, 2023.
  • Brainstorm Cell is a biotechnology company that develops and commercializes autologous cellular therapies for the treatment of neurodegenerative diseases.
  • For more information, submit a form , email Aaron Dumas, Jr., or give us a call at (800) 350-6003.
  • What Now: Similarly situated shareholders may be eligible to participate in the class action against Brainstorm Cell Therapeutics Inc. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP.

Golden Heaven Group Holdings Ltd. (GDHG) Shareholder Alert: Robbins LLP Reminds Shareholders of Class Action Filed Against Golden Heaven Group Holdings Ltd.

Retrieved on: 
Wednesday, December 27, 2023

Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Golden Heaven Group Holdings Ltd. (NASDAQ: GDHG) securities between April 13, 2023 and November 13, 2023.

Key Points: 
  • Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Golden Heaven Group Holdings Ltd. (NASDAQ: GDHG) securities between April 13, 2023 and November 13, 2023.
  • Golden Heaven has stated that it “manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities.
  • What Now: Similarly situated shareholders may be eligible to participate in the class action against Golden Heaven Holdings Ltd. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.